Skip to main content

Belvedere Trading LLC

SEC CIK
0001632341
Latest filing
Jul 31, 2026

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Belvedere Trading LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2022
Holdings of IBRX by Belvedere Trading LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−11,846−100.0%Sold outHolders
Q1 202311,846$21.6K<0.1%−8,064−40.5%ReducedHolders
Q4 202219,910$100.9K0.1%+2,127+12.0%AddedHolders
Q3 202217,783$96.0K0.1%−166−0.9%ReducedHolders
Q2 202217,949$78.0K0.1%+17,949NewHolders